The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EORTC CLTF 2018 | Regulation of PD-L1 in cutaneous lymphoma by miRNAs
Improving our understanding of how immune checkpoints are regulated in cutaneous T-cell lymphoma (CTCL) is essential to advancing our treatment of the disease using agents targeting these pathways. Here, Christiane Querfeld, MD, PhD, from City of Hope, Duarte, CA, discusses her group’s work on the regulation of PD-L1 expression by miRNAs in CTCL. This interview was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.
